|Articles|November 1, 2003

VACCINE LAUNCH EXPECTED

CancerVax expects to launch its therapeutic melanoma vaccine and lead product candidate Canvaxin by 2006.

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Latest CME